Sign Out
Ovidrel is indicated in the treatment of: Women undergoing superovulation prior to assisted reproductive technologies (ART) such as in vitro fertilisation (IVF). Ovidrel is administered to trigger final follicular maturation and luteinisation after stimulation of follicular growth.
Anovulatory or oligo-ovulatory women: Ovidrel is administered to trigger ovulation and luteinisation in anovulatory or oligo-ovulatory patients after stimulation of follicular growth.
